Financial Services

NUC University's rebrand to Northbridge isn't just a name change. It's a strategic expansion aimed at tackling national workforce shortages.

A state of emergency reveals deep flaws in Maine’s energy supply as major propane companies fail deliveries, leaving thousands of families at risk.

A new 40-unit housing project in Barrie offers an intensive, data-driven approach to help the unsheltered. Can this pilot become a national solution?

Chinese brand CHANDO presented a decade of research at IMCAS, revealing a new epigenetic mechanism that could revolutionize brightening for Asian skin.

Schweiter Technologies will unveil its 2025 results and 2026 strategy on Feb 27, with investors eager for signs of growth and profitability.

Mitchell Hamline School of Law is embedding AI into its curriculum, from chatbot study buddies to simulated disputes, to prepare practice-ready attorneys.

A new federal grant positions Curio's NuCycle technology to tackle nuclear waste, promising a cleaner, more sustainable American energy future.

As Timbercreek Financial preps its Q4 report, investors eye dividend health and asset quality as key indicators for the broader CRE market's new cycle.

A new report says letting utilities generate more power could save billions and cut outages. But does it kill competition and give monopolies too much power?

The medical device giant posts 6% Q1 growth but faces major challenges from US reimbursement changes and a China recall, banking on a new acquisition.

Air Transat lands in Rio de Janeiro, launching an exclusive Montreal route and challenging competitors in Toronto, backed by a key partnership with GOL.

Celebrating its 25th anniversary, Westgate Foundation invests $1.25M in 64 nonprofits, team member aid, and a new legacy scholarship.

A small-cap food company plans a major NASDAQ leap, but its future hinges on a secret 'clean' technology. Can this ambitious, risky pivot succeed?

New clinical data reveals a minimally invasive spine implant significantly cuts pain, improves function, and reduces opioid use for SI joint dysfunction.

Ernexa Therapeutics secures crucial funding for its cancer therapy pipeline, but the dilutive offering sends its stock plunging more than 50%.

An ultra-marathon from Altadena to the Palisades raises funds and spirits, symbolizing a community's enduring fight to rebuild from devastating wildfires.

How one firm's deep investment in local associations and talent development is shaping the future of the Southeast's booming multifamily housing market.

Nodal Exchange's record January highlights booming demand for energy and carbon derivatives as the green transition accelerates market volatility and risk.

Upexi's new funding bolsters its ambitious Solana treasury, but the deal's terms, including warrant adjustments, raise dilution concerns for investors.

The fragrance giant affirmed its $0.20 quarterly dividend, signaling stability to investors even as it navigates shifting consumer habits and a tough market.